Related Experiment Video
Updated: Jun 15, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
T regulatory cells, the evolution of targeted immunotherapy
S Nizar1, B Meyer, C Galustian
1Department of Cellular and Molecular Medicine, St George's University of London, UK.
Biochimica Et Biophysica Acta
|March 2, 2010
Summary
Regulatory T cells (Tregs) can hinder anti-tumour immunity. This review covers Treg immunology discoveries and their role in developing targeted immunotherapies and assessing therapeutic applications.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Regulatory T cells (Tregs) play a crucial role in immune suppression.
- Tregs can inhibit anti-tumour immune responses in both preclinical models and cancer patients.
- Understanding Treg function is vital for advancing cancer immunotherapy.
Purpose of the Study:
- To review key discoveries in Treg immunology.
- To highlight the evolution of targeted immunotherapies based on Treg research.
- To discuss current and future therapeutic applications of Treg modulation.
Main Methods:
- Literature review of Treg immunology.
- Analysis of Treg's role in anti-tumour immunity.
- Evaluation of Treg-targeted immunotherapies.
Main Results:
- Tregs are significant suppressors of anti-tumour immunity.
- Advances in Treg immunology have paved the way for novel immunotherapies.
- Various Treg-targeting strategies are under clinical investigation.
Conclusions:
- Targeting Tregs offers a promising avenue for enhancing cancer immunotherapy.
- Further research into Treg biology will likely yield more effective cancer treatments.
- The therapeutic potential of modulating Treg activity in cancer is substantial.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...